Dynamic changes of respiratory microbiota associated with treatment outcome in drug-sensitive and drug-resistant pulmonary tuberculosis.

Dynamic changes of respiratory microbiota associated with treatment outcome in drug-sensitive and drug-resistant pulmonary tuberculosis.

Publication date: Sep 09, 2024

Respiratory microbiota is closely related to tuberculosis (TB) initiation and progression. However, the dynamic changes of respiratory microbiota during treatment and its association with TB progression remains unclear. A total of 16 healthy individuals and 16 TB patients (10 drug-sensitive TB (DS-TB) and 6 drug-resistant TB (DR-TB)) were recruited. Sputum samples were collected at baseline for all anticipants and after anti-TB treatment at Month-6 for TB patients. High throughput 16 S RNA sequencing was used to characterize the respiratory microbiota composition. Compared to the healthy individuals, TB patients exhibited lower respiratory microbiota diversity (p 

Concepts Keywords
Healthy Adult
Microbiol Antitubercular Agents
Pulmonary Antitubercular Agents
Tuberculosis Bacteria
Female
Humans
Male
Microbiota
Middle Aged
Mycobacterium tuberculosis
Respiratory microbiota
RNA, Ribosomal, 16S
RNA, Ribosomal, 16S
Sputum
Treatment Outcome
Treatment outcome
Tuberculosis
Tuberculosis, Multidrug-Resistant
Tuberculosis, Pulmonary

Semantics

Type Source Name
disease MESH pulmonary tuberculosis
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease IDO bacteria
disease MESH Tuberculosis Multidrug-Resistant

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *